1. Home
  2. FATN vs KYTX Comparison

FATN vs KYTX Comparison

Compare FATN & KYTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATN
  • KYTX
  • Stock Information
  • Founded
  • FATN 1989
  • KYTX 2018
  • Country
  • FATN United States
  • KYTX United States
  • Employees
  • FATN N/A
  • KYTX N/A
  • Industry
  • FATN
  • KYTX
  • Sector
  • FATN
  • KYTX
  • Exchange
  • FATN NYSE
  • KYTX NYSE
  • Market Cap
  • FATN 111.3M
  • KYTX 92.1M
  • IPO Year
  • FATN 2025
  • KYTX 2024
  • Fundamental
  • Price
  • FATN $7.13
  • KYTX $2.11
  • Analyst Decision
  • FATN
  • KYTX Buy
  • Analyst Count
  • FATN 0
  • KYTX 5
  • Target Price
  • FATN N/A
  • KYTX $18.80
  • AVG Volume (30 Days)
  • FATN 815.7K
  • KYTX 203.0K
  • Earning Date
  • FATN 01-01-0001
  • KYTX 05-16-2025
  • Dividend Yield
  • FATN N/A
  • KYTX N/A
  • EPS Growth
  • FATN 56.77
  • KYTX N/A
  • EPS
  • FATN 0.37
  • KYTX N/A
  • Revenue
  • FATN $17,876,645.00
  • KYTX N/A
  • Revenue This Year
  • FATN N/A
  • KYTX N/A
  • Revenue Next Year
  • FATN N/A
  • KYTX N/A
  • P/E Ratio
  • FATN $19.69
  • KYTX N/A
  • Revenue Growth
  • FATN 13.17
  • KYTX N/A
  • 52 Week Low
  • FATN $5.60
  • KYTX $1.78
  • 52 Week High
  • FATN $23.27
  • KYTX $17.55
  • Technical
  • Relative Strength Index (RSI)
  • FATN N/A
  • KYTX 48.82
  • Support Level
  • FATN N/A
  • KYTX $1.92
  • Resistance Level
  • FATN N/A
  • KYTX $2.38
  • Average True Range (ATR)
  • FATN 0.00
  • KYTX 0.17
  • MACD
  • FATN 0.00
  • KYTX 0.02
  • Stochastic Oscillator
  • FATN 0.00
  • KYTX 41.30

About FATN FATPIPE INC

Fatpipe Inc is a pioneer in enterprise-class, application-aware, secure SD-WAN solutions for organizations, including enterprises, communication service providers, security service providers, government organizations, and other middle-market companies. It is engaged in delivering principal enterprise-class networking software technology. The company is dedicated to continually improving the way organizations connect, ensuring their networks are secure, reliable, and supporting their continued success. Its commitment lies in empowering its customers with a seamless and dependable connectivity infrastructure that safeguards their critical data and fosters business continuity. Further, the company's goal is to ensure its customers have unparalleled insights into their network operations.

About KYTX KYVERNA THERAPEUTICS INC

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.

Share on Social Networks: